Trial Profile
An Open-label, Sequence-randomized, Three-period, Six-sequence, Multiple Dosing Crossover Clinical Trial to Evaluate the Pharmacokinetic Interaction Between AD-2011 and AD-2012 in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Oct 2018
Price :
$35
*
At a glance
- Drugs AD-2011 (Primary) ; AD-2012 (Primary)
- Indications Hyperlipidaemia; Hypertension
- Focus Pharmacokinetics
- Sponsors Addpharma
- 08 Oct 2018 Status changed from recruiting to completed.
- 20 Jul 2018 New trial record